Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04305158 · ClinicalTrials.gov registry record · Early Phase 1
Colonoscopy Using Nitrous Oxide- A Pilot Study in the USA
A Early Phase 1 study of Nitrous Oxide, sponsored by University of Arkansas.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT04305158: Completed Early Phase 1 study of Nitrous Oxide, sponsored by University of Arkansas.
NCT04305158 is a Early Phase 1 study of Nitrous Oxide that has completed, run by University of Arkansas. The registered enrollment target is 200 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (277% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04305158, a Early Phase 1 study of Nitrous Oxide, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Colon cancer is the second most common cancer in men and the third most common cancer in women worldwide. The clinical objectives of administering sedation for GI endoscopy are to relieve patient anxiety and discomfort and to improve the outcome of the examination. Use of N2O could potentially provide an alternate safe and cheap option for patients who do not prefer IV sedation for colonoscopy
Primary Outcome
Time required to complete the procedure and reach end of the colon
Conditions Studied
Interventions
- DRUG Nitrous Oxide
Study Locations (1)
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-03-28 |
| Est. Completion | 2023-08-10 |
| Phase | Early Phase 1 |
What the finished NCT04305158 record still lists
NCT04305158 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (277% higher).
The record links to 1 condition, with Nitrous Oxide appearing as the primary indexed condition, and to 1 intervention - of which Nitrous Oxide is the first listed.
NCT04305158 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT04305158 about?
NCT04305158 is a clinical study titled "Colonoscopy Using Nitrous Oxide- A Pilot Study in the USA". Colon cancer is the second most common cancer in men and the third most common cancer in women worldwide. The clinical objectives of administering sedation for GI endoscopy are to relieve patient anxiety and discomfort and to improve the outcome of the examination. Use of N2O could potentially provi...
What is the current status of trial NCT04305158?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 200 participants. The study started on 2022-03-28. Estimated completion is 2023-08-10.
What conditions does trial NCT04305158 study?
This clinical trial studies the following conditions: Nitrous Oxide.
What interventions are being tested in trial NCT04305158?
The interventions under investigation include: Nitrous Oxide (DRUG).
Who is sponsoring clinical trial NCT04305158?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04305158 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04305158's enrollment target sits among peer trials
200 60th of 2000 higher than 1,934 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI